Treatment during pregnancy with the approved multiple sclerosis (MS) medication Copaxone (glatiramer acetate injection) does not appear to increase the risk of birth defects in infants, and its use while breastfeeding is not linked to growth problems in the youngsters, according to follow-up data of mothers and their children…
pregnancy
TG Therapeutics is conducting two post-marketing studies to determine how safe Briumvi (ublituximab-xiiy) is among people with relapsing forms of multiple sclerosis (MS) who are pregnant or breastfeeding, as well as their babies. The goal is to generate data on the use of Briumvi during pregnancy and lactation…
Women with a history of depression around the time they get pregnant are at increased risk of developing autoimmune diseases such as multiple sclerosis (MS), according to recent research. Likewise, women who have an autoimmune disease are more likely to get depressed during pregnancy and in the year after…
Women who smoked during pregnancy, and their offspring, showed a significantly higher risk of developing multiple sclerosis (MS) in a recent Danish study. “Our observations add further to the evidence implicating smoking in the development of MS and suggest that intra-uterine exposure to tobacco smoke may increase MS risk,”…
Disease relapses are no more likely in women with multiple sclerosis (MS) after fertility treatment than they were before such treatment, a study found. Researchers also observed that almost half of the women receiving fertility treatment were on disease-modifying MS therapies, which may have helped to keep a…
A new study of women with multiple sclerosis (MS) who had previously given birth may have identified one of the mechanisms behind the lasting protective effects of pregnancy seen in MS patients. Patients who’d had children were found to have a number of differences in methylation, a type of…
The use of disease-modifying therapies (DMTs) by pregnant women with multiple sclerosis (MS) significantly increased over the last decade or so, and fewer of them are stopping treatment before giving birth, a single-center study in Italy reported. While most patients (95.1%) discontinued a DMT while pregnant between 2005…
Treatment with Ocrevus (ocrelizumab) before or during pregnancy does not seem to increase the risk of major pregnancy or infant complications, with 79% of the pregnancies leading to live births, according to data from more than 2,000 women with multiple sclerosis (MS). The results were shared at the 38th…
The rates of pregnancy complications are not higher in women with multiple sclerosis (MS) who were using disease-modifying therapies (DMTs) in the earliest stages of pregnancy, a study reported. The study, “Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate or natalizumab in…
Women with multiple sclerosis (MS) are not at a higher risk of their babies having growth deficits during pregnancy or after birth than individuals without the disease, a study suggests. Yet, the data showed women with MS are significantly more likely to deliver their babies by cesarean section (C-section)…
Early Detection of Pseudobulbar Affect May Help Ease MS Symptom I often see posts on social media from people with MS asking if crying for no reason is an MS symptom, because it happens to them. I didn’t know that apparently, it is. Laughing, too. This report says…
The risk of developing multiple sclerosis (MS) is lower in women with a history of pregnancy and is not affected by the use of oral contraceptives, according to a recent meta-analysis of four published studies. However, the four studies, conducted in the U.S. and Iran, showed considerable variability in…
Taking Copaxone (glatiramer acetate), an approved therapy for relapsing forms of multiple sclerosis (MS), while breastfeeding does not appear to be harmful to infants during their first 18 months, according to a real-life study in Germany called COBRA. “In this study, we compared the development of 120 children in total, whose…
Exposure to Ocrevus (ocrelizumab) just before conception or during the first three months of pregnancy does not seem to increase the risk of adverse outcomes for women with multiple sclerosis (MS) or their babies, according to a small Australian study. All of the patients stopped taking Ocrevus upon…
Maternal or paternal exposure prior to conception to the multiple sclerosis (MS) therapy Aubagio (teriflunomide) does not seem to increase the risk of adverse pregnancy events, including miscarriage, preterm birth, small newborn size, or malformations, according to the results of a recent Danish study. About…
There has been a marked increase in the amount of research done regarding women’s health in multiple sclerosis (MS) over the last decade or two, but there remain substantial gaps in scientific knowledge, especially for topics outside of pregnancy, according to a scoping review. “Future studies are needed that…
The majority of multiple sclerosis (MS) patients who stop taking Tysabri (natalizumab) before or when they become pregnant experience a disease relapse during pregnancy or shortly thereafter, according to a study out of Germany. In more than one out of every 10 cases, relapses were so severe that…
Women with relapsing-remitting multiple sclerosis (RRMS) have more brain lesions and accelerated brain volume loss (BVL) after pregnancy compared with pre-pregnancy measurements, recent data showed. Brain lesions in the early postpartum period — the first months following childbirth — were associated with a higher risk of worsened disability and relapse…
Women with multiple sclerosis (MS) who receive high-efficacy disease-modifying therapies (DMTs) before conception have a greater risk of relapses and disability progression during pregnancy than those given moderate-efficacy or no DMTs, according to a systematic review of studies. Exclusive breastfeeding for at least two to four months, however,…
“Rock bottom is the end of what wasn’t true enough. Begin again and build something Truer.” — Glennon Doyle The first of our four pregnancy losses were our twin daughters in 2013, which happened nearly halfway through my pregnancy. Three years later, the first symptoms appeared that would eventually would…
Having at least one pregnancy may lower disability scores in women with multiple sclerosis (MS), but breastfeeding for longer than six months may worsen damage to the brain, an observational study in patients has found. Findings support the need for careful pregnancy planning, counseling, and treatment management to ensure…
The presence of a light-sensing protein in the brain during the early stages of fetal development may help to explain why certain neurological diseases, like multiple sclerosis (MS), are more common among people born at specific times of the year, a study found. The researchers, who noted that people…
Children born to women with multiple sclerosis (MS) are not at a higher risk of brain disorders than are children whose mothers don’t have this disease, an observational study reported. However, children born to women with a family with a history of other autoimmune conditions and brain disorders, or…
Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Women with multiple sclerosis (MS) who continue taking disease-modifying therapies (DMTs) throughout pregnancy accrue lower non-maternity healthcare…
Treatment with rituximab before or during pregnancy was not associated with major pregnancy or infant complications, according to a case series of 19 women with multiple sclerosis (MS) and other autoimmune diseases. These findings add to the limited available evidence on the use of rituximab by expectant mothers either…
Proteins called PSGs suppress the pro-inflammatory activity of immune Th17 cells during pregnancy, potentially playing a protective role against complications and miscarriage, a study finds. The impaired regulation of Th17 is associated with pregnancy complications, like preeclampsia and preterm delivery — and also with the development…
Children of diabetic mothers may be at more risk of developing multiple sclerosis (MS), a Danish national study suggests. The study, “Maternal diabetes and risk of multiple sclerosis in the offspring: A Danish nationwide register-based cohort study,” was published in the Multiple Sclerosis Journal. Previous studies have suggested a…
Women who have never given birth are more likely to develop early onset of progressive multiple sclerosis, according to a new study, which also found that a woman’s number of pregnancies showed a positive effect in delaying the disease. In addition, entering menopause earlier, before the age of 46,…
MS Prevalence at Over 2.8 Million Worldwide, Update to Atlas Reports With almost 3 million of us around the world, we’re not really rare, but we’re rare enough that our MS is still a puzzle to many. People seem to know what muscular dystrophy is (probably because of the…
After a pregnancy or childbirth, most women who went on to develop clinically isolated syndrome (CIS) did so about three years later than those who were never pregnant, a large and multicenter study reported. Multiple pregnancies or births, however, were not seen to further affect CIS onset. More research is…